Our COMPANY Mission
To be a recognised as a market leader in innovative Point of Care diagnosis, matching each patient’s critical condition to the right treatment at the right time.
Our Mission Statement
We are delivering a leading Point of Care diagnostic platform that people rely on to significantly reduce costs and anxiety. In offering this innovative solution to B2B partners in each clinical segment, we aim to reach the greatest number of patients worldwide in the shortest possible time.
Our Company Values
These are the practical things we believe in and they directly inform the decisions we make and actions taken to deliver our ‘Vision’.
Everything we do is directed to make sure that patients are in control and at the forefront of their medical care.
In order to support patients, we must support our B2B customers and address their business needs.
Our test development has to deliver accurate results. Working with our customers, we must ensure precision and clinical evidence of efficacy.
AGPLUS PLATFORM DEVLOPMENT
We are proud to have developed a tried and tested B2B commercial approach to Assay Development. We strive to progress partnerships including technology licensing, development plus manufacture and supply, with collaborators in a variety of applications and business sectors.
To work in conjunction with our proven assay development service, we are proud to have launched our diagnostic reader. The Agilis Reader provides a robust solution for gathering fast and quantitative data which is fully connected with a global network.